Fraunhofer Translational Center Regenerative Therapies TLC-RT

Cancer Immunotherapy through Local T-Cell Activation

The "KITAMAKI" project develops innovative approaches for treating skin metastases in breast cancer through local T-cell activation using monoclonal antibodies on biocompatible RENACER^®-fibers. This also provides effective treatment options for other cancers, such as malignant melanoma. Follow­ing validation, a drug prototype will be ready, offering a cost-effective and safe therapeutic option.

3D bioprinting aims to enable the fabrication of living organs and tissues at the push of a button, but it faces the challenge of replicating physiological tissue structure. In the "PhysioINK" project, printing inks made from natural tissue proteins are being developed to mimic the physiological structure. The goal is to achieve printability under cell-compatible conditions, as well as to control tissue assembly through simple triggers and the avoidance of chemical modifications.

Innovative wound care for wound healing in space

With a revolutionary project for faster and better wound healing in space as well as on Earth, the research team “StellarHeal” wins 1st place in the Innospace Master Challenge of the German Space Agency at DLR. Congratulations to our colleagues Dr. Dieter Groneberg and Dr. Bastian Christ on this success!

• Standardized in vitro test systems
• Disease models
• hiPSC technologies